CoChat

A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder

Heinz, Michael V., Price, George D., Singh, Avijit, Bhattacharya, Sukanya, Chen, Ching-Hua, Asyyed, Asma, Does, Monique B., Hassanpour, Saeed, Hichborn, Emily, Kotz, David, Lambert-Harris, Chantal A., Li, Zhiguo, McLeman, Bethany, Mishra, Varun, Stanger, Catherine, Subramaniam, Geetha, Wu, Weiyi, Campbell, Cynthia I., Marsch, Lisa A., Jacobson, Nicholas C. · 2025 · Journal of Substance Use and Addiction Treatment
Cited by 10

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.josat.2025.209685

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 47

  1. Aaron, 2020, Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use, American Psychologist, 75, 796, 10.1037/amp0000678 · DOI · Paper page
  2. Alexander, 2023, The use of ecological momentary assessment methods with people receiving medication for opioid use disorder: A systematic review, Current Addiction Reports, 10, 366, 10.1007/s40429-023-00492-5 · DOI
  3. Bertz, 2022, Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplace, Behaviour Research and Therapy, 152, 10.1016/j.brat.2022.104071 · DOI
  4. Biondi, 2020, A literature review examining primary outcomes of medication treatment studies for opioid use disorder: What outcome should be used to measure opioid treatment success?, Am. J. Addict., 29, 249, 10.1111/ajad.13051 · DOI
  5. Campbell, 2023, Patient engagement in a multimodal digital phenotyping study of opioid use disorder, Journal of Medical Internet Research, 25, 10.2196/45556 · DOI
  6. Chalana, 2016, Predictors of relapse after inpatient opioid detoxification during 1-year follow-up, Journal of Addiction, 2016, 10.1155/2016/7620860 · DOI
  7. Chang, 2021, Factors associated with relapse in individuals with opioid use disorder receiving suboxone in rural areas, Journal of Addictions Nursing, 32, 20, 10.1097/JAN.0000000000000381 · DOI
  8. Chung, J., Gulcehre, C., Cho, K., & Bengio, Y. (2014). Empirical evaluation of gated recurrent neural networks on sequence modeling (arXiv:1412.3555). arXiv. doi:10.48550/arXiv.1412.3555. · DOI · Paper page
  9. Ellis, 2018, Twin epidemics: The surging rise of methamphetamine use in chronic opioid users, Drug and Alcohol Dependence, 193, 14, 10.1016/j.drugalcdep.2018.08.029 · DOI · Paper page
  10. Fischer, 2021, ‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America, Substance Abuse Treatment, Prevention, and Policy, 16, 17, 10.1186/s13011-021-00350-5 · DOI
  11. Fishman, 2020, Treatment trajectories during and following a medication trial for opioid use disorder: Moving from research as usual to treatment as usual, Journal of Addiction Medicine, 14, 331, 10.1097/ADM.0000000000000592 · DOI
  12. Franques, 2003, Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study, Drug and Alcohol Dependence, 69, 121, 10.1016/S0376-8716(02)00309-5 · DOI
  13. Gold, 2020, Emotion regulation and motives for illicit drug use in opioid-dependent patients, Cognitive Behaviour Therapy, 49, 74, 10.1080/16506073.2019.1579256 · DOI
  14. Gottlieb, 2022, Machine Learning for Predicting Risk of Early Dropout in a Recovery Program for Opioid Use Disorder, Healthcare, 10, 223, 10.3390/healthcare10020223 · DOI
  15. Heinz, 2024, Evaluating a mobile app’s effects on depression and anxiety in medication-treated opioid use disorder, Npj Mental Health Research, 3, 1, 10.1038/s44184-024-00086-7 · DOI
  16. Heiwe, 2011, Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication, European Journal of Pain, 15, 966, 10.1016/j.ejpain.2011.03.006 · DOI · Paper page
  17. Howard, 2019, Mothers and opioid use disorder: Moving toward justice, wellness, and engagement, Journal of the American Academy of Matrimonial Lawyers, 32, 29
  18. Keyes, 2022, What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size, Drug and Alcohol Dependence Reports, 3, 10.1016/j.dadr.2022.100052 · DOI · Paper page
  19. Kraus, 2011, Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction, Journal of Addiction Medicine, 5, 254, 10.1097/ADM.0b013e3182312983 · DOI · Paper page
  20. Lichenstein, 2019, Mechanisms and clinical features of co-occurring opioid and nicotine use, Current Addiction Reports, 6, 114, 10.1007/s40429-019-00245-3 · DOI
  21. Ling, 2003, AUC: A better measure than accuracy in comparing learning algorithms, Vol. 2671, 329
  22. Lundberg, 2017, A unified approach to interpreting model predictions, Advances in Neural Information Processing Systems, 4765
  23. Lutz, 2018, Difficulties in emotion regulation and chronic pain-related disability and opioid misuse, Addictive Behaviors, 87, 200, 10.1016/j.addbeh.2018.07.018 · DOI · Paper page
  24. Ma, 2019, Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis, Molecular Psychiatry, 24, 1868, 10.1038/s41380-018-0094-5 · DOI · Paper page
  25. MacArthur, 2012, Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis, BMJ (Clinical Research Ed.), 345
  26. Marcovitz, 2016, Predictors of early dropout in outpatient buprenorphine/naloxone treatment, Am. J. Addict., 25, 472, 10.1111/ajad.12414 · DOI
  27. Maricich, 2021, Real-world evidence for a prescription digital therapeutic to treat opioid use disorder, Current Medical Research and Opinion
  28. Marino, 2013, Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain, Addictive Behaviors, 38, 2154, 10.1016/j.addbeh.2013.01.020 · DOI
  29. Marsch, 2022, The feasibility and utility of harnessing digital health to understand clinical trajectories in medication treatment for opioid use disorder: D-TECT study design and methodological considerations, Frontiers in Psychiatry, 13, 10.3389/fpsyt.2022.871916 · DOI
  30. Mattson, 2021, Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019, Morbidity and Mortality Weekly Report, 70, 202, 10.15585/mmwr.mm7006a4 · DOI · Paper page
  31. McCurry, 2023, Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare, Journal of Nursing Scholarship, 55, 701, 10.1111/jnu.12837 · DOI
  32. Mishra, 2021, Detecting receptivity for mHealth interventions in the natural environment, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, 5, 74, 10.1145/3463492 · DOI
  33. Morris, 2020, Nicotine and opioids: A call for co-treatment as the standard of care, The Journal of Behavioral Health Services & Research, 47, 601, 10.1007/s11414-020-09712-6 · DOI
  34. Mun, 2021, Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: An ecological momentary assessment study, Addiction, 116, 1794, 10.1111/add.15344 · DOI
  35. Naji, 2016, A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone, Substance Abuse: Research and Treatment, 10, 9
  36. Olfson, 2018, Cannabis use and risk of prescription opioid use disorder in the United States, The American Journal of Psychiatry, 175, 47, 10.1176/appi.ajp.2017.17040413 · DOI · Paper page
  37. Palis, 2022, Association of opioid and stimulant use disorder diagnoses with fatal and nonfatal overdose among people with a history of incarceration, JAMA Network Open, 5, 10.1001/jamanetworkopen.2022.43653 · DOI
  38. Perski, 2022, Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: A systematic review, Addiction (Abingdon, England), 117, 1220, 10.1111/add.15687 · DOI · Paper page
  39. Ponizovsky, 2007, Quality of life among heroin users on buprenorphine versus methadone maintenance, The American Journal of Drug and Alcohol Abuse, 33, 631, 10.1080/00952990701523698 · DOI · Paper page
  40. Riquino, 2018, Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients, Borderline Personality Disorder and Emotion Dysregulation, 5, 11, 10.1186/s40479-018-0088-6 · DOI
  41. Samples, 2018, Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees, Journal of Substance Abuse Treatment, 95, 9, 10.1016/j.jsat.2018.09.001 · DOI · Paper page
  42. Scherer, 2022, Momentary self-regulation: Scale development and preliminary validation, JMIR Mental Health, 9, 10.2196/35273 · DOI
  43. Shiffman, 2008, Ecological momentary assessment, Annual Review of Clinical Psychology, 4, 1, 10.1146/annurev.clinpsy.3.022806.091415 · DOI · Paper page
  44. Tlachac, 2022, DepreST-CAT: Retrospective smartphone call and text logs collected during the COVID-19 pandemic to screen for mental illnesses, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, 6, 1
  45. Weinstein, 2017, Long-term retention in office based opioid treatment with buprenorphine, Journal of Substance Abuse Treatment, 74, 65, 10.1016/j.jsat.2016.12.010 · DOI · Paper page
  46. White, 2020, Assessment of work loss associated with prescription-related opioid use disorder: A retrospective analysis of claims data, Journal of Occupational and Environmental Medicine, 62, 217, 10.1097/JOM.0000000000001802 · DOI
  47. Yedinak, 2019, Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment, PLoS Medicine, 16, 10.1371/journal.pmed.1002963 · DOI

Metadata

Authors
Heinz, M. V., Price, G. D., Singh, A., Bhattacharya, S., Chen, C.-H., Asyyed, A., Does, M. B., Hassanpour, S., Hichborn, E., Kotz, D., Lambert-Harris, C. A., Li, Z., McLeman, B., Mishra, V., Stanger, C., Subramaniam, G., Wu, W., Campbell, C. I., Marsch, L. A., & Jacobson, N. C.
Venue
Journal of Substance Use and Addiction Treatment
Publisher
Elsevier BV
Published
2025-06
Volume
173
Pages
209685
ISSN
2949-8759
Cited by
10
References
8
Language
en
Licence
Funders
  • National Institute on Drug Abuse
  • National Institute on Drug Abuse Clinical Trials Network (UG1DA040309, UG1DA040314)
  • NIH (T32 CA134286)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder. https://app.cochat.ai/papers/10.1016/j.josat.2025.209685
The paper
Heinz, M. V., Price, G. D., Singh, A., Bhattacharya, S., Chen, C.-H., Asyyed, A., Does, M. B., Hassanpour, S., Hichborn, E., Kotz, D., Lambert-Harris, C. A., Li, Z., McLeman, B., Mishra, V., Stanger, C., Subramaniam, G., Wu, W., Campbell, C. I., Marsch, L. A., & Jacobson, N. C. (2025). A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder. Journal of Substance Use and Addiction Treatment. https://doi.org/10.1016/j.josat.2025.209685

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.